Nawin Kumar

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai et al. · The Lancet · 2011 · 334 citations

Clinical Epidemiology, Pharmacotherapy, Short-course Multidrug Treatment +3

Asymptomatic Infection with Visceral Leishmaniasis in a Disease-Endemic Area in Bihar, India

Roshan Kamal Topno, Vidya Nand Rabi Das, Alok Ranjan et al. · American Journal of Tropical Medicine and Hygiene · 2010 · 94 citations · Full text

High Density, Vector-borne Pathogen, Parasitic Disease +13

Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.

Vidya Nand Rabi Das, Alok Ranjan, Sanjeev Bimal et al. · PubMed · 2005 · 63 citations

Oral miltefosine for Indian post‐kala‐azar dermal leishmaniasis: a randomised trial

Shyam Sundar, Prabat Sinha, T. K. Jha et al. · Tropical Medicine & International Health · 2012 · 60 citations · Full text

Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases

C.P. Thakur, Geeta Sinha, Avinash Pandey et al. · Annals of Tropical Medicine and Parasitology · 1998 · 46 citations

Translational Medicine, Ventricular Fibrillation, Antiparasitic Agent +8